PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The mouse that ROR'ed

ROR1 oncogene combines with another to accelerate, worsen blood cancer

2014-01-02
(Press-News.org) Contact information: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
The mouse that ROR'ed ROR1 oncogene combines with another to accelerate, worsen blood cancer Researchers at the University of California, San Diego School of Medicine report that an oncogene dubbed ROR1, found on chronic lymphocytic leukemia (CLL) B cells but not normal adult tissues, acts as an accelerant when combined with another oncogene, resulting in a faster-developing, more aggressive form of CLL in mice.

The findings, published in the Dec. 30, 2013 Online Early Edition of PNAS, suggest ROR1 could be an important therapeutic target for patients with CLL, the most common form of blood cancer. Prevalence of CLL in the United States is high: 1 in 20 people over the age of 40 could have apparently pre-cancerous CLL-like cells in their blood. These people may develop actual CLL at a rate of about 1 percent per year. More than 15,000 new cases of CLL are diagnosed each year in the United States. Roughly 4,400 patients with CLL die annually.

The work by principal investigator Thomas Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research, and colleagues continues a series of discoveries about ROR1. Previously, for example, they found an association between ROR1 and the epithelial-mesenchymal transition – the process that occurs during embryogenesis when cells migrate and then grow into new organs during early development. CLL cells exploit ROR1 to spread disease. Called metastasis, it is responsible for 90 percent of cancer-related deaths.

In the PNAS paper, Kipps and colleagues created transgenic mice that expressed human ROR1, then observed that these mice produced B cells (a kind of white blood cell) that were abnormal and resembled human CLL cells while non-transgenic littermates did not.

Next they crossed the ROR1 mice with another transgenic mouse-type that produces an oncogene called TCL1. Oncogenes are genes that can lead to cancer development if over-expressed or mutated. The progeny of these cross-bred mice possessed both oncogenes – ROR1 and TCL1 – and consequently displayed an even greater proclivity toward developing aggressive, fast-acting CLL.

When researchers treated the mice with an anti-ROR1 monoclonal antibody that reduces levels of ROR1, the CLL cells were impaired and more vulnerable to treatment and destruction. Based on these findings, Kipps said investigators at UC San Diego Moores Cancer Center are planning clinical trials in 2014 using a humanized monoclonal antibody that has the same type of activity against human leukemia or cancer cells that express ROR1.

### Co-authors are George F. Widhopf II, Bing Cui, Emanuela M. Ghia and Liguang Chen, Department of Medicine, UCSD; Karen Messer, Department of Biostatistics/Bioinformatics, UCSD; Zhouxin Shen and Steven P. Briggs, Cell & Developmental Biology, UCSD; and Carlo M. Croce, Ohio State University School of Medicine.

Funding support came, in part, from the National Institutes of Health grants PO1-CA081534 and R37-CA049870, California Institute for Regenerative Medicine (DR1-01430) and the UC San Diego Foundation Blood Cancer Research Fund.

Disclosure: Thomas Kipps is a member of the Scientific Advisory Boards of Celgene Corporation and Igenica Inc, which have a financial interest in the reported research.


ELSE PRESS RELEASES FROM THIS DATE:

New MRI technique illuminates the wrist in motion

2014-01-02
New MRI technique illuminates the wrist in motion (SACRAMENTO, Calif.) — If a picture is worth 1,000 words then a movie is worth far more, especially when it comes to diagnosing wrist problems. UC Davis radiologists, medical physicists ...

Virginia Tech researchers find novice teen drivers easily fall into distraction, accidents

2014-01-02
Virginia Tech researchers find novice teen drivers easily fall into distraction, accidents Cell phones, other distractions pose greater threat to teen drivers Teens may begin their driving habits with great caution, but as months behind the wheel pass, they begin to multi-task ...

Novel noninvasive therapy prevents breast cancer formation in mice

2014-01-02
Novel noninvasive therapy prevents breast cancer formation in mice Injectable therapy could help people avoid mastectomy BOSTON – A novel breast-cancer therapy that partially reverses the cancerous state in cultured breast ...

Research into fruit fly cells could lead to cancer insights

2014-01-02
Research into fruit fly cells could lead to cancer insights New research by scientists at the University of Exeter has shown that cells demonstrate remarkable flexibility and versatility when it comes to how they divide - a finding with potential links ...

Alcohol, tobacco, drug use far higher in severely mentally ill

2014-01-02
Alcohol, tobacco, drug use far higher in severely mentally ill In the largest ever assessment of substance use among people with severe psychiatric illness, researchers at Washington University School of Medicine in St. Louis and the University of Southern ...

Tripling tobacco taxes worldwide would avoid 200 million tobacco deaths

2014-01-02
Tripling tobacco taxes worldwide would avoid 200 million tobacco deaths Controlling tobacco marketing is also key to helping people quit smoking TORONTO, Jan. 2, 2014—Tripling taxes on cigarettes around the world would reduce the number of smokers by one-third ...

US global share of research spending declines

2014-01-02
US global share of research spending declines New analysis shows Asia gaining, due to increased support from both government, industry ANN ARBOR, Mich. — The United States' global share of biomedical research spending fell from 51 percent in 2007 ...

Drivers engaged in other tasks about 10 percent of the time

2014-01-02
Drivers engaged in other tasks about 10 percent of the time NIH, Virginia Tech study shows crash risks greatest for teens Drivers eat, reach for the phone, text, or otherwise take their eyes off the road about 10 percent of the time ...

High blood pressure potentially more dangerous for women than men

2014-01-02
High blood pressure potentially more dangerous for women than men WINSTON-SALEM, N.C. – Jan. 2, 2014 – Doctors may need to treat high blood pressure in women earlier and more aggressively than they do in men, according to scientists at Wake Forest ...

To grow or to defend: How plants decide

2014-01-01
To grow or to defend: How plants decide Crop breeding for semi-dwarfed plants could also improve disease resistance Scientists have discovered how plants use steroid hormones to choose growth over defence when their survival depends on it. The findings ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] The mouse that ROR'ed
ROR1 oncogene combines with another to accelerate, worsen blood cancer